Fund HoldingsB Group, Inc.

Total Portfolio Value
$176.19M
Total Bought
$30.48M
Total Sold
$2.25M
Net Transaction
+$28.23M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
FAETH THERAPEUTICS INC(FTH)0610,169+610,169015,2548.66%+15,254
NRX PHARMACEUTICALS INC(NRXP)3,000,0004,091,767+1,091,7676,39016,7359.50%+10,345
TAYSHA GENE THERAPIES INC(TSHA)1,800,5561,800,55608,04812,2626.96%+4,213
PALISADE BIO INC(PALI)11,414,28511,414,285019,97523,85613.54%+3,881
ORUKA THERAPEUTICS INC(ORKA)75,00075,00003,6797,1384.05%+3,459
ULTRAGENYX PHARMACEUTICAL IN(RARE)135,000135,00002,8284,5082.56%+1,679
AURA BIOSCIENCES INC(AURA)597,576764,243+166,6673,9985,4263.08%+1,428
STRUCTURE THERAPEUTICS INC127,500140,000+12,5006,1467,5144.26%+1,368
SPYRE THERAPEUTICS INC(SYRE)100,00070,000-30,0005,0446,2153.53%+1,171
IOVANCE BIOTHERAPEUTICS INC(IOVA)1,500,0001,500,00005,2656,2403.54%+975
FOGHORN THERAPEUTICS INC(FHTX)102,000200,000+98,0004889760.55%+488
PRAXIS PRECISION MEDICINES I(PRAX)33,23733,237010,70911,1276.32%+419
ZAI LAB LTD(ZLAB)450,646450,64608,4778,5624.86%+86
SIGHT SCIENCES INC(SGHT)970,000970,00003,6573,6572.08%0
ASSEMBLY BIOSCIENCES INC175,706175,70604,8764,8282.74%-47
BRIGHT MINDS BIOSCIENCES INC(DRUG)67,50067,50004,9254,7392.69%-187
REPLIMUNE GROUP INC(REPL)26,0000-26,0001990-199
SOLENO THERAPEUTICS INC7,5000-7,5002510-251
CELLECTIS S A(CLLS)3,281,5013,281,501010,4029,8455.59%-558
APOGEE THERAPEUTICS INC(APGE)7,5000-7,5006310-631
ADMA BIOLOGICS INC3,207,5423,262,542+55,00028,90027,30715.50%-1,592
Page 1 of 1
B Group, Inc. — 13F Holdings — Q2 2026 | TickerTrail